Company · CIK 1739410
Rallybio Corp
| CIK | 1739410 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CT |
| Listed | RLYB (Nasdaq) |
| First annual or quarterly report | 2021-09-09 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-266668 | 2022-08-08 | 2025-03-13 | 6 | |
| 333-279317 | 2024-05-10 | 2024-05-20 | 2 | |
| 333-271748 | 2023-05-09 | 2023-05-12 | 2 | |
| 333-257655 | 2021-07-02 | 2021-07-30 | 4 |
Filings
17| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-10-15 | EFFECTDeclared effective | 333-297483 | 9999999995-26-003252 |
| 2026-05-05 | RWWithdrawn | 333-294361 | 0001193125-26-206462 |
| 2025-03-13 | 424B5Shelf takedown | 333-266668 | 0001193125-25-053960 |
| 2024-05-20 | EFFECTDeclared effective | 333-279317 | 9999999995-24-001593 |
| 2024-05-10 | S-3Shelf registered | 333-279317 | 0001193125-24-136133 |
| 2023-05-12 | EFFECTDeclared effective | 333-271748 | 9999999995-23-001418 |
| 2023-05-09 | S-3Shelf registered | 333-271748 | 0001193125-23-138977 |
| 2022-11-14 | 424B5Shelf takedown | 333-266668 | 0001193125-22-283756 |
| 2022-11-10 | 424B5Shelf takedown | 333-266668 | 0001193125-22-282070 |
| 2022-08-15 | EFFECTDeclared effective | 333-266668 | 9999999995-22-002385 |
| 2022-08-15 | 424B5Shelf takedown | 333-266668 | 0001193125-22-221342 |
| 2022-08-08 | S-3Shelf registered | 333-266668 | 0001193125-22-215079 |
| 2021-07-30 | 424B4Final prospectus | 333-257655 | 0001193125-21-230254 |
| 2021-07-28 | EFFECTDeclared effective | 333-257655 | 9999999995-21-002956 |
| 2021-07-22 | S-1/AAmendment | 333-257655 | 0001193125-21-221832 |
| 2021-07-02 | S-1Registration filed | 333-257655 | 0001193125-21-207662 |
| 2021-04-27 | DRSDraft made public | 377-04734 | 0000950123-21-004979 |